196 related articles for article (PubMed ID: 30245753)
1. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
Tang T; Yang C; Brown HE; Huang J
Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
[TBL] [Abstract][Full Text] [Related]
3. Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.
Balázs M; Zsolt H; László G; Gabriella G; Lilla T; Gyula O; Balázs D; Éva M; Zoltán B; Zoltán P; Judit K
Pathol Oncol Res; 2017 Apr; 23(2):377-383. PubMed ID: 27704355
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic efficiency of seven autoantibodies in lung cancer.
Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
[TBL] [Abstract][Full Text] [Related]
6. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z
Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 70 is a useful marker for predicting colorectal cancer.
Gunaldi M; Kocoglu H; Okuturlar Y; Gedikbasi A; Karabulut M; Alis H; Hursitoglu M
J BUON; 2015; 20(6):1464-70. PubMed ID: 26854442
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
Gao F; Chang J; Wang H; Zhang G
Oncol Rep; 2014 Jan; 31(1):351-7. PubMed ID: 24190459
[TBL] [Abstract][Full Text] [Related]
10. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
11. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
[TBL] [Abstract][Full Text] [Related]
12. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
13. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
14. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
[TBL] [Abstract][Full Text] [Related]
15. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
[TBL] [Abstract][Full Text] [Related]
16. The Value of Combination Analysis of Tumor Biomarkers for Early Differentiating Diagnosis of Lung Cancer and Pulmonary Tuberculosis.
Jia H; Zhang L; Wang B
Ann Clin Lab Sci; 2019 Sep; 49(5):645-649. PubMed ID: 31611208
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
Ni J; Guo Z; Zhang L
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
19. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
[TBL] [Abstract][Full Text] [Related]
20. Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.
Yang J; Jiao S; Kang J; Li R; Zhang G
Int J Clin Exp Pathol; 2015; 8(11):14959-64. PubMed ID: 26823828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]